Alvotech Enters Next Stage For Entyvio Rival

Confirmatory Patient Study Begins For AVT16, One Of Two Proposed Vedolizumab Biosimilars

 
• By Dave Wallace
  
Player 01 vs Player 02
Alvotech sees itself as one of only two players on vedolizumab • Source: Shutterstock

More from Biosimilars

More from Products